Breakthrough biomaterial heals tissue from the inside out

Scientists at the University of California San Diego have developed an innovative injectable biomaterial that can travel through the bloodstream to repair damaged tissue from within, offering a less invasive and potentially transformative approach to healing. In animal studies, the intravenous hydrogel successfully treated heart attack damage by reducing inflammation and promoting tissue repair. The material also showed promise for other inflammation-driven conditions, including traumatic brain injury and pulmonary arterial hypertension. This breakthrough differs from previous therapies that required direct injection into the heart, as the new biomaterial can be administered intravenously, allowing it to disperse evenly and act quickly throughout the body. The hydrogel is derived from the natural extracellular matrix of cardiac muscle tissue, enabling it to support regeneration by providing a scaffold for healing. The research team, led by bioengineering professor Karen Christman, published their findings in Nature Biomedical Engineering and anticipates human trials to test safety and effectiveness could begin within the next one to two years. Heart attacks remain a leading cause of death and disability, with nearly 785,000 new cases annually in the United States alone. Current treatments focus on restoring blood flow and managing symptoms but do not directly repair damaged heart tissue, which often scars and weakens the heart muscle over time. This new biomaterial could fill a critical gap by promoting tissue regeneration and potentially reducing the progression to congestive heart failure. Cardiologists like Dr. Ryan R. Reeves emphasize the urgent need for therapies that improve outcomes for patients suffering from coronary artery disease and heart failure. The development represents a significant advance in regenerative medicine, offering a novel method to treat damaged organs from the inside out. If successful in human trials, this injectable biomaterial could revolutionize the management of heart disease and other conditions characterized by inflammation and tissue injury, ultimately improving recovery and quality of life for millions of patients worldwide.